These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 21902680)
1. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols. Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E Br J Haematol; 2011 Oct; 155(2):235-43. PubMed ID: 21902680 [TBL] [Abstract][Full Text] [Related]
2. Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol. Kuchinskaya E; Heyman M; Nordgren A; Söderhäll S; Forestier E; Wehner P; Vettenranta K; Jonsson O; Wesenberg F; Sahlén S; Nordenskjöld M; Blennow E Br J Haematol; 2011 Mar; 152(5):615-22. PubMed ID: 21241277 [TBL] [Abstract][Full Text] [Related]
3. Interphase FISH to detect PBX1/E2A fusion resulting from the der(19)t(1;19)(q23;p13.3) or t(1;19)(q23;p13.3) in paediatric patients with acute lymphoblastic leukaemia. Shearer BM; Flynn HC; Knudson RA; Ketterling RP Br J Haematol; 2005 Apr; 129(1):45-52. PubMed ID: 15801954 [TBL] [Abstract][Full Text] [Related]
4. High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies. Vaitkevičienė G; Forestier E; Hellebostad M; Heyman M; Jonsson OG; Lähteenmäki PM; Rosthoej S; Söderhäll S; Schmiegelow K; Eur J Haematol; 2011 Jan; 86(1):38-46. PubMed ID: 21077959 [TBL] [Abstract][Full Text] [Related]
5. Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival. Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Rosenquist R; Swolin B; Johansson B; ; ; Br J Haematol; 2008 Mar; 140(6):665-72. PubMed ID: 18241254 [TBL] [Abstract][Full Text] [Related]
6. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013. Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335 [TBL] [Abstract][Full Text] [Related]
7. Formation of der(19)t(1;19)(q23;p13) in acute lymphoblastic leukemia. Paulsson K; Horvat A; Fioretos T; Mitelman F; Johansson B Genes Chromosomes Cancer; 2005 Feb; 42(2):144-8. PubMed ID: 15543624 [TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group. Forestier E; Johansson B; Gustafsson G; Borgström G; Kerndrup G; Johannsson J; Heim S Br J Haematol; 2000 Jul; 110(1):147-53. PubMed ID: 10930992 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial. Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF; Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166 [TBL] [Abstract][Full Text] [Related]
10. Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol. Barbany G; Andersen MK; Autio K; Borgström G; Franco LC; Golovleva I; Heim S; Heinonen K; Hovland R; Johansson B; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E; ; ; Leuk Res; 2012 Jul; 36(7):936-8. PubMed ID: 22521551 [No Abstract] [Full Text] [Related]
11. Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature. Forestier E; Gauffin F; Andersen MK; Autio K; Borgström G; Golovleva I; Gustafsson B; Heim S; Heinonen K; Heyman M; Hovland R; Johannsson JH; Kerndrup G; Rosenquist R; Schoumans J; Swolin B; Johansson B; Nordgren A; ; ; Genes Chromosomes Cancer; 2008 Feb; 47(2):149-58. PubMed ID: 17990329 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Secker-Walker LM; Berger R; Fenaux P; Lai JL; Nelken B; Garson M; Michael PM; Hagemeijer A; Harrison CJ; Kaneko Y Leukemia; 1992 May; 6(5):363-9. PubMed ID: 1593901 [TBL] [Abstract][Full Text] [Related]
13. Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: rare T-cell receptor gene rearrangements are associated with poor outcome. Karrman K; Forestier E; Heyman M; Andersen MK; Autio K; Blennow E; Borgström G; Ehrencrona H; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kerndrup G; Nordgren A; Palmqvist L; Johansson B; ; ; Genes Chromosomes Cancer; 2009 Sep; 48(9):795-805. PubMed ID: 19530250 [TBL] [Abstract][Full Text] [Related]
14. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology. Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G; J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981 [TBL] [Abstract][Full Text] [Related]
15. Post-induction residual disease in translocation t(12;21)-positive childhood ALL. Seyfarth J; Madsen HO; Nyvold C; Ryder LP; Clausen N; Jonmundsson GK; Wesenberg F; Schmiegelow K Med Pediatr Oncol; 2003 Feb; 40(2):82-7. PubMed ID: 12461790 [TBL] [Abstract][Full Text] [Related]
16. Analysis of ETV6/RUNX1 fusions for evaluating the late effects of cancer therapy in ALL (acute lymphoblastic leukemia) cured patients. Brassesco MS; Camparoto ML; Tone LG; Sakamoto-Hojo ET Cytogenet Genome Res; 2004; 104(1-4):346-51. PubMed ID: 15162063 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Heerema NA; Sather HN; Sensel MG; Lee MK; Hutchinson R; Nachman JB; Lange BJ; Steinherz PG; Bostrom B; Gaynon PS; Uckun FM Cancer; 2000 Apr; 88(8):1945-54. PubMed ID: 10760773 [TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP). Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914 [TBL] [Abstract][Full Text] [Related]
19. High incidence of the ETV6/RUNX1 fusion gene in paediatric precursor B-cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: a Nordic series of cases diagnosed 1989-2005. Karrman K; Forestier E; Andersen MK; Autio K; Borgström G; Heim S; Heinonen K; Hovland R; Kerndrup G; Johansson B; Br J Haematol; 2006 Nov; 135(3):352-4. PubMed ID: 16965388 [TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy. Pichler H; Möricke A; Mann G; Teigler-Schlegel A; Niggli F; Nebral K; König M; Inthal A; Krehan D; Dworzak MN; Janousek D; Harbott J; Schrappe M; Gadner H; Strehl S; Haas OA; Panzer-Grümayer R; Attarbaschi A; Br J Haematol; 2010 Apr; 149(1):93-100. PubMed ID: 20067563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]